Stock Price Quote

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE476.40-5.1 (-1.06 %)
PREV CLOSE ( ) 481.50
OPEN PRICE ( ) 483.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5006
TODAY'S LOW / HIGH ( )475.00 488.45
52 WK LOW / HIGH ( )233.25 591.5
NSE477.55-5.2 (-1.08 %)
PREV CLOSE( ) 482.75
OPEN PRICE ( ) 484.00
BID PRICE (QTY) 477.55 (103)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 94155
TODAY'S LOW / HIGH( ) 475.00 488.70
52 WK LOW / HIGH ( )236.03 589
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-11 1990
Management Info
Sivalinga Prasad Vasireddi - Chairman Harita Vasireddi - Managing Director
Registered Office

Address Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R District,
Hyderabad,
Telangana-500051

Phone 040- 27264141

Email shares@vimta.com

Website www.vimta.com

Registrars Details
Cil Securities Ltd
214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,,Hyderabad
Listing : BSE, NSE

NEWS

13Jun Cancellation of Board Meeting
(Cancelled) The Board Meeting to be held on 14/06/2025 Stands Cancelled.
09Jun Allotment of Bonus Equity Shares
inter alia,, to consider and approve the allotment of bonus equity share..
29Apr Vimta Labs gets nod for foray into bio
Vimta Labs has received approval for foray into biologics contract resea..
29Apr Vimta Labs gains on getting nod for fo
Vimta Labs is currently trading at Rs. 1038.00, up by 16.90 points or 1...
23Apr Vimta Labs informs about board meeting
Vimta Labs has informed that the meeting of the Board of Directors of th..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit183.19673.42
Gross Profit 250.27 890
Operating Profit 346.771261.89
Net Sales 944.413439.82

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  31529.10 (1.67%)
M.Cap ( in Cr)66997.14
Sanofi Cons. Health (BSE)
peergroup  5075.20 (2.17%)
M.Cap ( in Cr)11688.50
JB Chem & Pharma (BSE)
peergroup  1771.25 (5.98%)
M.Cap ( in Cr)27657.06
Divi's Lab (BSE)
peergroup  6589.85 (1.49%)
M.Cap ( in Cr)174939.81
Wockhardt (BSE)
peergroup  1730.65 (2.58%)
M.Cap ( in Cr)28120.56

Shareholding Pattern

NON-INSTITUTION 58.2%
PROMOTERS 36.7%
FI/BANKS/INSURANCE 0.01%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Vimta Labs Ltd.

Vimta Labs Ltd. was incorporated in the year 1990. Its today's share price is 476.4. Its current market capitalisation stands at Rs 2120.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3439.82 Cr and Total Income of Rs.3482.22 Cr. The company's management includes Sujani Vasireddi, Yadagiri R Pendri, Sanjay Dave, Satya Sreenivas Neerukonda, Harriman Vungal, Purnachandra Rao Gutta, Prameela Rani Yalamanchili, Harita Vasireddi, Sivalinga Prasad Vasireddi.

It is listed on the BSE with a BSE Code of 524394 , NSE with an NSE Symbol of VIMTALABS and ISIN of INE579C01029. It's Registered office is at Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R DistrictHyderabad-500051, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Gattamaneni & Co, JVSL & Associates, Sarathy & Balu

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.